Hepatic fibrosis mice treated with ADSC-EXO showed significantly decrease in glutamate level but increase in glutamine level compared with DEN/CCl4 group mice, which suggested that the elevated Glul induced by ADSC-EXO treatment enhanced the conversion of glutamate to glutamine (Fig. 6L). This evidence concerns the gene GLUL and Hepatic fibrosis.